Literature DB >> 3552584

Non-steroidal anti-inflammatory analgesics other than salicylates.

R N Brogden.   

Abstract

The largest group of non-narcotic analgesics are the arylalkanoic acid derivatives, comprising derivatives of arylacetic acid, propionic acid, heteraryl acetic acid and indole acetic acid. Common to all of these drugs is their inhibition of prostaglandin biosynthesis, which contributes to their analgesic and other pharmacological properties as well as to their principal side effect, gastrointestinal irritation. Although these drugs all cause some gastric microbleeding, they do so to a lesser extent than aspirin. The arylalkanoic acid derivatives, as well as the anthranilic acid and oxicam derivatives, are peripherally acting as evidenced by their lack of activity in classical tests of central analgesic activity. After oral administration of these drugs, their peak plasma concentrations are generally attained in 1 to 3 hours; absorption is not generally influenced by food. Volume of distribution is mostly low (less than 0.2 L/kg) and protein binding is high (usually 95 to 99%). Elimination is by glucuronide formation for several of the propionic acid derivatives and generally by biotransformation for derivatives of arylacetic acid, indole and indene acetic acid, and the oxicams. The elimination half-life of the arylalkanoic acid derivatives is in most instances about 2 to 5 hours, although notable exceptions include carprofen (approximately equal to 20 h), fenbufen (10 h), naproxen (12-15 h) and sulindac (16 h for the active metabolite). The elimination half-life of indomethacin varies considerably between and within individuals. Piroxicam has the longest half-life, averaging 45 hours. The pharmacokinetic properties of the anthranilic acid derivatives (fenamates, glafenine) generally resemble those of the arylacetic acids. Few clinically significant drug interactions are associated with concomitant administration of the arylalkanoic acids or piroxicam and other drugs. Since the arylalkanoic acids are highly bound to plasma proteins (mainly albumin) there is a theoretical potential for displacement reactions with drugs that are used at plasma concentrations high enough to exceed the binding capacity of their own primary binding sites. However, such reactions have rarely been reported. Although the concomitant administration of aspirin and several of the propionic acid derivatives results in a significant decrease in the plasma concentration of the latter, the clinical significance of such interactions is uncertain and probably minimal.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3552584     DOI: 10.2165/00003495-198600324-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  50 in total

1.  A controlled study of the analgetic effect of two non-steroidal anti-inflammatory drugs in cancer pain.

Authors:  G Martino; A Emanueli; V Mandelli; V Ventafridda
Journal:  Arzneimittelforschung       Date:  1978

2.  An evaluation of the analgesic efficacy of proquazone and aspirin in postoperative dental pain.

Authors:  J A Forbes; R W White; E H White; M K Hughes
Journal:  J Clin Pharmacol       Date:  1980-07       Impact factor: 3.126

3.  Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine.

Authors:  R A Upton; J N Buskin; R L Williams; N H Holford; S Riegelman
Journal:  J Pharm Sci       Date:  1980-11       Impact factor: 3.534

4.  Combination therapy with ibuprofen and methadone for chronic cancer pain.

Authors:  T Ferrer-Brechner; P Ganz
Journal:  Am J Med       Date:  1984-07-13       Impact factor: 4.965

5.  The efficacy of etodolac for patients with pain following oral surgery.

Authors:  G W Gaston; R D Mallow; J E Frank
Journal:  J Oral Maxillofac Surg       Date:  1984-06       Impact factor: 1.895

6.  Evaluation of the analgesic properties of zomepirac.

Authors:  T P Pruss; J F Gardocki; R J Taylor; L D Muschek
Journal:  J Clin Pharmacol       Date:  1980-04       Impact factor: 3.126

7.  Pharmacokinetic studies on diclofenac sodium in young and old volunteers.

Authors:  J V Willis; M J Kendall
Journal:  Scand J Rheumatol Suppl       Date:  1978

8.  Double-blind comparison of single oral doses of oxaprozin, aspirin, and placebo for relief of post-operative oral surgery pain.

Authors:  L Winter; A Post
Journal:  J Int Med Res       Date:  1983       Impact factor: 1.671

9.  [Treatment of postoperative wound pain with suprofen].

Authors:  A Fassolt; H Stocker
Journal:  Arzneimittelforschung       Date:  1983

10.  Piroxicam, a structurally novel anti-inflammatory compound. Mode of prostaglandin synthesis inhibition.

Authors:  T J Carty; J S Stevens; J G Lombardino; M J Parry; M J Randall
Journal:  Prostaglandins       Date:  1980-05
View more
  11 in total

1.  [Not Available].

Authors:  E Hackenthal
Journal:  Schmerz       Date:  1990-09       Impact factor: 1.107

2.  Efficacy and tolerability of an injectable formulation of tiaprofenic acid in patients with acute back and neck pain.

Authors:  R Scarpa; P Oriente; S Longatti
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 3.  Differences in NSAID tolerability profiles. Fact or fiction?

Authors:  K J Skeith; M Wright; P Davis
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 4.  Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy.

Authors:  K McCormack; K Brune
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

5.  Effects of naproxen on the in vivo synthesis of thromboxane and prostacyclin in man.

Authors:  O Vesterqvist; K Gréen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 6.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 7.  Single dose oral fenbufen for acute postoperative pain in adults.

Authors:  R Andrew Moore; Sheena Derry; Henry J McQuay
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

Review 8.  Pharmacokinetics of common analgesics, anti-inflammatories and antipyretics in children.

Authors:  P D Walson; M E Mortensen
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

9.  Kynurenine metabolites and migraine: experimental studies and therapeutic perspectives.

Authors:  Annamária Fejes; Arpád Párdutz; József Toldi; László Vécsei
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

Review 10.  Inhibitors of connexin and pannexin channels as potential therapeutics.

Authors:  Joost Willebrords; Michaël Maes; Sara Crespo Yanguas; Mathieu Vinken
Journal:  Pharmacol Ther       Date:  2017-07-15       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.